In the news

Panel discussions and presentations are planned at a meeting this month for the second phase of the Indiana Clinical and Translational Sciences Institute (CTSI), a partnership between Purdue University, Indiana University and the University of Notre Dame.

WEST LAFAYETTE, Ind.  A team of scientists from Purdue University and the University of Michigan have captured the structure of a protein that could lead to new treatments for dengue and West Nile viruses.

The Indiana Clinical and Translational Sciences Institute, a partnership among Indiana University, Purdue University and the University of Notre Dame, has received nearly $30 million from the National Institutes of Health to continue its mission accelerating research discoveries across Indiana and beyond. The Clinical and Translational Sciences Award from the NIH's National Center for Advancing Translational Sciences renews the grant that established the Indiana CTSI five years ago, guaranteeing the institution will advance innovative health care programs and biomedical research into at least 2018.

Purdue University researchers successfully eliminated the native infection preferences of a Sindbis virus engineered to target and kill cancer cells, a milestone in the manipulation of this promising viral vector.

Informatics Research Specialist with Bindley Bioscience Center Lead a team of informatics specialists to design, create and implement informatics solutions for data from proteomics, metabolomics, genomics, and other high volume life sciences research projects. Develop new informatics projects with external funding. Compile, analyze and summarize data, report findings in written form for manuscripts, reports and grant applications.

Purdue University is known for its cutting edge research, but as scientists study in labs in every corner of campus, there is one place where their theories can be realized. Purdue's Discovery Park and the Bindley Bioscience Center held "Discovery Day" to highlight a wide range of research being done by faculty.

When the National Institutes of Health created the National Center for Advancing Translational Sciences, which houses the Clinical and Translational Sciences Award program that supports the Indiana Clinical and Translational Sciences Institute, NIH Director Francis Collins pinpointed accelerating the development of diagnostics and therapeutics as an important goal of the new center. Meanwhile, Purdue University, an institutional member of the Indiana CTSI along with Indiana University and the University of Notre Dame, is emerging as a leader in the field of drug discovery with construction underway on a new $25-million Drug Discovery Building, opening in 2014, and a new virtual center aimed at discovering new treatments for conditions such as cancer and inflammatory disease.

Thanks to biotechnology and biological engineering professors at Purdue University, several high school students and their teachers are better prepared for this week's International Genetically Engineered Machines competition on synthetic biology research.

WEST LAFAYETTE, Ind. - Purdue University researchers revealed how a mutation in a protein shuts down a protective function needed to prevent the death of neurons in Parkinson's disease, possibly opening the door to new drug strategies to treat the disorder.

WEST LAFAYETTE, Ind. - Purdue University scientists will use a $1 million grant from the W.M. Keck Foundation to develop technologies for altering the epigenetic marks in the genome that turn genes on and off, work they hope will lead to advances in treating genetic health conditions.